1. Home
  2. ADXN vs MCVT Comparison

ADXN vs MCVT Comparison

Compare ADXN & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • MCVT
  • Stock Information
  • Founded
  • ADXN 2002
  • MCVT 2007
  • Country
  • ADXN Switzerland
  • MCVT United States
  • Employees
  • ADXN N/A
  • MCVT N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • MCVT Finance Companies
  • Sector
  • ADXN Health Care
  • MCVT Finance
  • Exchange
  • ADXN Nasdaq
  • MCVT Nasdaq
  • Market Cap
  • ADXN 11.3M
  • MCVT 13.2M
  • IPO Year
  • ADXN N/A
  • MCVT N/A
  • Fundamental
  • Price
  • ADXN $7.80
  • MCVT $1.96
  • Analyst Decision
  • ADXN Strong Buy
  • MCVT
  • Analyst Count
  • ADXN 1
  • MCVT 0
  • Target Price
  • ADXN $30.00
  • MCVT N/A
  • AVG Volume (30 Days)
  • ADXN 56.3K
  • MCVT 9.6K
  • Earning Date
  • ADXN 11-22-2024
  • MCVT 11-12-2024
  • Dividend Yield
  • ADXN N/A
  • MCVT N/A
  • EPS Growth
  • ADXN N/A
  • MCVT N/A
  • EPS
  • ADXN 0.05
  • MCVT 0.05
  • Revenue
  • ADXN $960,641.00
  • MCVT $3,234,265.00
  • Revenue This Year
  • ADXN N/A
  • MCVT N/A
  • Revenue Next Year
  • ADXN N/A
  • MCVT N/A
  • P/E Ratio
  • ADXN $1.44
  • MCVT $39.49
  • Revenue Growth
  • ADXN N/A
  • MCVT N/A
  • 52 Week Low
  • ADXN $5.00
  • MCVT $1.86
  • 52 Week High
  • ADXN $27.90
  • MCVT $3.88
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 31.62
  • MCVT 41.63
  • Support Level
  • ADXN $7.86
  • MCVT $1.88
  • Resistance Level
  • ADXN $9.89
  • MCVT $2.20
  • Average True Range (ATR)
  • ADXN 0.93
  • MCVT 0.09
  • MACD
  • ADXN -0.35
  • MCVT 0.00
  • Stochastic Oscillator
  • ADXN 4.57
  • MCVT 25.00

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About MCVT Mill City Ventures III Ltd.

Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.

Share on Social Networks: